WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/032935    International Application No.:    PCT/MX2000/000053
Publication Date: 25.04.2002 International Filing Date: 13.12.2000
Chapter 2 Demand Filed:    13.07.2001    
C07K 14/47 (2006.01), C07K 16/18 (2006.01)
Applicants: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO [MX/MX]; Edificio "B", 3er Piso, Zona Cultural, Ciudad Universitaria, Delegación Coyoacán, México, D.F. 04510 (MX) (For All Designated States Except US).
ALONSO GARCIA, Ana Lucía [MX/MX]; (MX) (For US Only).
MAS OLIVA, Jaime [MX/MX]; (MX) (For US Only)
Inventors: ALONSO GARCIA, Ana Lucía; (MX).
MAS OLIVA, Jaime; (MX)
Agent: OJESTO MARTINEZ PORCAYO, Daniel; Edificio "B", 3er Piso, Zona Cultural, C.P. 04510 Mexico, D.F., Delegación Coyoacán (MX)
Priority Data:
9911575 13.12.1999 MX
Abstract: front page image
(EN)The invention relates to an immunoenzymatic method for the quantification of protein CETP in plasma, which requires the utilization of fusion protein GST/CETP, the synthetic peptide CETP H486-S496 and polyclonal antibody anti-CEPT H486-S496. The method is used in the study of pathologies involving alterations in the CETP levels in plasma or in seric lipids and makes it possible to detect, evaluate and follow-up patients suffering from dyslipidemia and/or risk of altergenesis.
(ES)Método inmunoenzimatico para cuantificar la proteina CETP en plasma que requiere el uso de la proteina de fusion GST/CETP, el peptido sintetico CETP H486-S496 y el anticuerpo policlonal anti-CEPT H486-S496. Este metodo se aplica en el estudio de patologias que implican alteraciones de los niveles de CETP en plasma o niveles de lipidos sericos y permite la deteccion, evaluacion y sequimiento de pacientes con dislipidemia y/o riesgo de altergenesis.
(FR)L'invention concerne une méthode immunoenzymatique de quantification de la protéine CETP dans du plasma. Cette méthode fait appel à la protéine de fusion GST/CETP, au peptide synthétique CETP H486-S496 et à l'anticorps polyclonal anti-CEPT H486-S496. Cette méthode s'applique à l'étude de pathologies qui impliquent des altérations des niveaux de CETP dans le plasma ou des niveaux de lipides sériques et permet de détecter, d'évaluer et de surveiller des patients souffrant de dyslipidémie et/ou de risque d'altergenèse.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)